Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-06-07
2011-06-07
Kolker, Daniel E (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07955812
ABSTRACT:
The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease.
REFERENCES:
patent: WO 99/27944 (1999-06-01), None
patent: WO 02/00245 (2002-01-01), None
patent: WO 03/104437 (2003-12-01), None
Weksler 2002 (Experimental Gerontology 37:943-948).
Du 2001 (Neurology 57:801-805).
Xu 1997 (Mechanisms of Ageing and Development 94:213-222).
Head 2001 (Neurobiology of Disease 8:792-806).
Atwood, C. S. et al., “Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β,”Biochemistry2004; 43:560-568.
Atwood, C. S. et al., “Copper Catalyzed Oxidation of Alzheimer Aβ,”Cellular and Molecular Biology2000; 46(4):777-783.
Bush, A. I. et al., “The galvanization of β-amyloid in Alzheimer's disease,”PNASMay 28, 2002; 99(11):7317-7319.
Gong, Y. et al., “Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss,”PNASSep. 2, 2003; 100(18):10417-10422.
Hock, C. et al., “Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease,”NeuronMay 22, 2003; 38:547-554.
Moir, R. D. et al., “Autoantibodies to Redox-modified Oligomeric Aβ Are Attenuated in the Plasma of Alzheimer's Disease Patients,”The Journal of Biological ChemistryApr. 29, 2005; 280(17):17458-17463.
Roher, A. E. et al., “Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease,”The Journal of Biological ChemistryAug. 23, 1996; 271(34):20631-20635.
Walsh, D. M. et al., “The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain,”Biochemistry2000; 39:10831-10839.
Moir Robert
Tanzi Rudolph
Kolker Daniel E
The General Hospital Corporation
Wolf Greenfield & Sacks P.C.
LandOfFree
Methods of diagnosing alzheimer's disease by detecting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of diagnosing alzheimer's disease by detecting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of diagnosing alzheimer's disease by detecting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2717293